Trial Search Results

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

We hypothesize that all human malignancies harbour a subpopulation of tumor initiating cells/cancer stem cells (CSCs) that drives tumor development and potentially recurrence or metastasis of the disease. The primary aim of this study is to develop strategies for prospective isolation/enrichment of CSCs from human tumors of different tissue origins. In addition, we will characterize the signaling pathways and/or tumor specific antigens that are specific for CSCs, in order to specifically target these CSCs as the endpoint of this study.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Providence Foundation

Stanford Investigator(s):

Phase:

N/A

Eligibility


Inclusion Criteria:N/A. We will recruit all non-melanoma skin and bladder cancer patients
that are recommended for surgical removal of tumor tissues. This includes patients from all
ages, gender and ethnicity background. Our sample collection criteria based on the tumor
size of individual (e.g. tumor samples will only be collected if it will not affect the
pathological diagnosis or treatment procedures of patients).

Exclusion Criteria:N/A

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Linda Quinn
650-723-6520
Not Recruiting